Author: Centurión, Osmar Antonio; Scavenius, Karina E.; GarcÃa, Laura B.; Torales, Judith M.; Miño, LuÃs M.
Title: Potential Mechanisms of Cardiac Injury and Common Pathways of Inflammation in Patients With COVID-19 Cord-id: rhvv3l0l Document date: 2020_6_9
ID: rhvv3l0l
Snippet: Due to the lack of prospective, randomized, controlled clinical studies on inflammation and cardiovascular involvement, the exact mechanism of cardiac injury among patients with Coronavirus Disease 2019 (COVID-19) still remains uncertain. It was demonstrated that there is a high and significantly positive linear correlation between troponin T and plasma high-sensitivity C-reactive protein levels, biomarkers of cardiac injury and systemic inflammation, respectively. Cardiac injury and inflammatio
Document: Due to the lack of prospective, randomized, controlled clinical studies on inflammation and cardiovascular involvement, the exact mechanism of cardiac injury among patients with Coronavirus Disease 2019 (COVID-19) still remains uncertain. It was demonstrated that there is a high and significantly positive linear correlation between troponin T and plasma high-sensitivity C-reactive protein levels, biomarkers of cardiac injury and systemic inflammation, respectively. Cardiac injury and inflammation is a relatively common association among patients hospitalized with COVID-19, and it is related to higher risk of in-hospital mortality. In our literature search, we identified several potential mechanisms of myocardial tissue damage, namely, coronavirus-associated acute myocarditis, angiotensin-converting enzyme 2 receptor binding affinity to the virus Spike protein, increased cytokine secretion, and hypoxia-induced cardiac myocyte apoptosis. Elucidation of the disease pathogenesis and prospective histopathological studies are crucial for future proper treatment in case of renewed outbreaks. Of interest is that with hundred of thousands of bodies available for autopsy studies, no prospective investigation has been reported so far. Strong efforts and continued research of the cardiovascular complications and identification of risk factors for poor prognosis in COVID-19 are steadily needed. The high morbidity and mortality of COVID-19, its monumental economic burden and social impact, the despair of a new pandemic outbreak, and the thread of potential utilization of novel severe acute respiratory syndrome coronavirus 2 as biologic weapons make it a preponderant necessity to better comprehend the therapeutic management of this lethal disease. Emerging as an acute infectious disease, COVID-19 may become a chronic epidemic because of genetic recombination. Therefore, we should be ready for the reemergence of COVID-19 or other coronaviruses.
Search related documents:
Co phrase search for related documents- acute myocardial infarction and lung injury: 1, 2, 3
- acute myocardial infarction and lupus erythematosus: 1
- acute myocardial infarction and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute myocardial injury and lung injury: 1, 2, 3, 4
- acute myocardial injury and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute myocarditis and lung alveolar: 1, 2
- acute myocarditis and lung failure: 1, 2, 3
- acute myocarditis and lung injury: 1, 2, 3, 4, 5, 6, 7
- acute myocarditis and lupus erythematosus: 1
- acute myocarditis and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- acute patient cardiac injury and lung injury: 1
Co phrase search for related documents, hyperlinks ordered by date